Amanote Research
Register
Sign In
PIK3CA Mutation Predicts Resistance to Breast Cancer Therapy
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2013-180
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
December 19, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Predicting Response/Resistance to Endocrine Therapy for Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
A Novel Hotspot Specific Isothermal Amplification Method for Detection of the Common PIK3CA p.H1047R Breast Cancer Mutation
Scientific Reports
Multidisciplinary
Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Alpelisib Extends PFS in PIK3CA-Mutant Breast Cancer
Cancer Discovery
Oncology
LRG1 mRNA Expression in Breast Cancer Associates With PIK3CA Genotype and With Aromatase Inhibitor Therapy Outcome
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
PIK3CA Mutation Detection in Metastatic Biliary Cancer Using Cell-Free DNA
Oncotarget
Oncology
Prevalence and Characteristics of PIK3CA Mutation in Mismatch Repair-Deficient Colorectal Cancer
Journal of Cancer
Oncology
An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
PLoS ONE
Multidisciplinary
